Breaking News Instant updates and real-time market news.

AVGR

Avinger

$1.29

-0.01 (-0.77%)

08:09
03/13/18
03/13
08:09
03/13/18
08:09

Avinger announces three additions to U.S. intellectual property portfolio

Avinger announced three recent additions to its U.S. intellectual property portfolio. The U.S. Patent and Trademark Office has issued U.S. Patent No. 9,854,979, titled "Chronic Total Occlusion Crossing Devices with Imaging." In addition, the USPTO has provided an Issue Notification for U.S. Patent Application No. 13/752,325, titled "Catheter System and Method for Boring Through Blocked Vascular Passages," which is expected to issue as U.S. Patent No. 9,918,734 on March 20, 2018 and has provided a Notice of Allowance for certain claims in U.S. Patent Application No. 14/433,786, titled "Occlusion-Crossing Devices." All three of these patents relate to Avinger's portfolio of technologies used for crossing completely blocked arteries, also referred to as chronic total occlusions or CTOs, in both the peripheral and coronary arteries. The Company's Ocelot device is the only image-guided CTO-crossing catheter cleared for sale in the U.S. by the FDA. It demonstrated 97% success in crossing CTOs in peripheral arteries and a 98% freedom from major adverse events in the 100-patient CONNECT II study, which supported the device's FDA clearance in 2012.

  • 19

    Mar

AVGR Avinger
$1.29

-0.01 (-0.77%)

04/11/17
COWN
04/11/17
NO CHANGE
Target $2
COWN
Outperform
Cowen still believes in Avinger despite cutting target to $2
Cowen analyst Joshua Jennings says he remains a believer in the "unique value" of Avinger's proprietary Pantheris atherectomy device. Management has taken "reasonable steps" by cutting the workforce and accelerating the exploration of strategic options, Jennings tells investors in a research note. He cut his price target for the shares to $2 from $12 and keeps an Outperform rating on the name. The stock in midday trading is down 50% to 80c.
04/12/17
OPCO
04/12/17
DOWNGRADE
OPCO
Perform
Avinger downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Steven Lichtman downgraded Avinger to Perform from Outperform after its Q1 sales came in below estimates on lower than expected Pantheris utilization and following the company's announcement that it plans to reduce its workforce by 33%, while pursuing strategic alternatives, including a capital raise from strategic investors, OUS partnerships, or a merger/sale.
04/12/17
04/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Sell from Hold at Rafferty Capital with analyst Richard Bove saying he does not expect bank stocks in general to do well for months and he thinks on Wells specifically that its Directors report indicates that the company is in the midst of a multi-year re-structuring process. Bove lowered his 12-month price target range for Wells Fargo shares to $46-$60 from $52-$68. 2. Tractor Supply (TSCO) was downgraded to Equal Weight from Overweight at Stephens and to Neutral from Overweight at JPMorgan. 3. Avinger (AVGR) downgraded to Perform from Outperform at Oppenheimer with analyst Steven Lichtman downgraded Avinger (AVGR) to Perform from Outperform after its Q1 sales came in below estimates on lower than expected Pantheris utilization and following the company's announcement that it plans to reduce its workforce by 33%, while pursuing strategic alternatives, including a capital raise from strategic investors, OUS partnerships, or a merger/sale. 4. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at Buckingham with the firm citing recent share strength that has made risk/reward more balanced. 5. LVMH (LVMUY) downgraded to Hold from Buy at Societe Generale with analyst Thierry Cota citing a lack of upside following the stock's recent rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/09/18
LTCO
03/09/18
INITIATION
Target $3.25
LTCO
Buy
Avinger initiated with a Buy at Ladenburg
Ladenburg initiated Avinger with a Buy and $3.25 price target.

TODAY'S FREE FLY STORIES

HRTX

Heron Therapeutics

$24.70

0.28 (1.15%)

15:20
03/19/19
03/19
15:20
03/19/19
15:20
Options
6X average daily option volume in Heron Therapeautics driven by call spreads »

6X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HNP

Huaneng Power

$23.42

-0.47 (-1.97%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Downgrade
Huaneng Power rating change  »

Huaneng Power downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.88

0.21 (0.48%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Options
Smartsheet options imply 12.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 05

    Apr

VALE

Vale

$13.90

0.62 (4.67%)

15:18
03/19/19
03/19
15:18
03/19/19
15:18
Hot Stocks
Vale reports reestablishment of Guaiba Island Terminal activities »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/19/19
03/19
15:17
03/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/19/19
03/19
15:16
03/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.24

0.54 (2.38%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Conference/Events
Mallinckrodt management to meet with Mizuho »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

SYMC

Symantec

$23.27

0.19 (0.82%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Options
Put buyers sizing up new positions in Symantec far downside strikes »

Put buyers sizing up new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

GATX

GATX

$76.90

0.21 (0.27%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Conference/Events
GATX management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

BA

Boeing

$375.00

2.9 (0.78%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Periodicals
DOT asks department watchdog to audit approval of Boeing 737, Bloomberg says »

Transportation Secretary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BA

Boeing

$375.07

2.97 (0.80%)

15:05
03/19/19
03/19
15:05
03/19/19
15:05
Periodicals
Breaking Periodicals news story on Boeing »

DOT asks Inspector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

TME

Tencent Music

$19.33

0.2 (1.05%)

15:04
03/19/19
03/19
15:04
03/19/19
15:04
Options
Tencent options imply 12.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NAII

Natural Alternatives International

$11.20

-0.17 (-1.50%)

15:01
03/19/19
03/19
15:01
03/19/19
15:01
Hot Stocks
Natural Alternatives says Court of Appeals rules in its favor in patent suit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/19/19
03/19
15:00
03/19/19
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KEM

Kemet

$18.34

0.02 (0.11%)

14:56
03/19/19
03/19
14:56
03/19/19
14:56
Conference/Events
Kemet management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

DBD

Diebold

$11.07

-0.33 (-2.89%)

14:55
03/19/19
03/19
14:55
03/19/19
14:55
Options
Diebold put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$25.68

2.43 (10.45%)

, GOOG

Alphabet

$1,195.81

12.15 (1.03%)

14:54
03/19/19
03/19
14:54
03/19/19
14:54
Hot Stocks
AMD says Radeon GPUs being used for Google Stadia platform »

AMD (AMD) announced that…

AMD

AMD

$25.68

2.43 (10.45%)

GOOG

Alphabet

$1,195.81

12.15 (1.03%)

GOOGL

Alphabet Class A

$1,199.72

11.63 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

SIEN

Sientra

$9.26

0.05 (0.54%)

14:51
03/19/19
03/19
14:51
03/19/19
14:51
Hot Stocks
Breaking Hot Stocks news story on Sientra »

Sientra down 6% after FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNS

WNS Holdings

$52.87

-0.14 (-0.26%)

14:50
03/19/19
03/19
14:50
03/19/19
14:50
Conference/Events
WNS Holdings management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

JCOM

j2 Global

$86.67

0.76 (0.88%)

14:49
03/19/19
03/19
14:49
03/19/19
14:49
Conference/Events
j2 Global management to meet with Wedbush »

Luncheon and Dinner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FDX

FedEx

$182.02

-0.4 (-0.22%)

14:49
03/19/19
03/19
14:49
03/19/19
14:49
Options
Fedex options imply 8.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

SIEN

Sientra

$9.26

0.05 (0.54%)

14:48
03/19/19
03/19
14:48
03/19/19
14:48
Hot Stocks
FDA posts warning letter sent to Sientra »

In a letter dated March…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMASY

Inmarsat

$0.00

(0.00%)

14:46
03/19/19
03/19
14:46
03/19/19
14:46
Hot Stocks
Inmarsat confirms receipt of potential $7.21 per share offer from PE consortium »

The Board of Inmarsat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$269.61

0.15 (0.06%)

14:45
03/19/19
03/19
14:45
03/19/19
14:45
Periodicals
Tesla, Musk face dozens of suits, probes, CNBC says »

Tesla and CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

GLUU

Glu Mobile

$10.46

0.59 (5.98%)

14:45
03/19/19
03/19
14:45
03/19/19
14:45
Options
Glu Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.